Forum probiodrug geopend
Euronext:
Company Profile:
Probiodrug specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.At the end of 2015, the group has a portfolio of 2 products in preclinical development phase (PBD-C06 and PQ1565) and a product in phase I of clinical development (PQ912).
Groet Henk
IEX - Forummoderator schreef op 28 januari 2017 09:11:
Euronext:
Company Profile:
Probiodrug specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.At the end of 2015, the group has a portfolio of 2 products in preclinical development phase (PBD-C06 and PQ1565) and a product in phase I of clinical development (PQ912).
Groet Henk
Beste Henk,
Bedankt voor het openen van dit forum. Ik zal later vandaag starten met inhoud. Overigens zit PQ912 inmiddels in phase II.
Direct naar Forum
Detail
| Vertraagd |
31 mrt 2023 17:35 |
| Koers |
15,260 |
| Verschil |
+0,540 (+3,67%) |
| Hoog |
15,300 |
| Laag |
14,300 |
| Volume |
102.383 |
| Volume gemiddeld |
75.085 |
| Volume gisteren |
66.786 |